Dianthus Therapeutics(DNTH)
$89.30+0.49 (+0.55%)
DNTH
Dianthus Therapeutics financials statements
$89.30
At close:+0.49 (+0.55%)
Want to see DNTH full AI Analyst Report?
Dianthus Therapeutics (DNTH) Financial Statements
446 Followers
Dianthus Therapeutics Financial Overview
Dianthus Therapeutics's market cap is currently $5.00B. The company's EPS TTM is $0.03; its P/E ratio is 2976.67; Dianthus Therapeutics is estimated to report earnings on March 16, 2027, and the estimated EPS forecast is $-0.96. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.04M | $ 6.24M | $ 2.83M | $ 6.42M | $ 1.48M |
| Gross Profit | $ 2.04M | $ 6.24M | $ 2.83M | $ 6.42M | $ 1.48M |
| Operating Income | $ -177.93M | $ -101.86M | $ -48.17M | $ -29.70M | $ -13.09M |
| EBITDA | $ -161.91M | $ -84.56M | $ -43.20M | $ -28.33M | $ -11.09M |
| Net Income | $ -162.34M | $ -84.97M | $ -43.55M | $ -28.48M | $ -13.11M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 404.30M | $ 275.24M | $ 173.72M | $ 75.49M | $ 176.93M |
| Total Assets | $ 530.92M | $ 374.01M | $ 179.41M | $ 83.11M | $ 189.93M |
| Total Debt | $ 1.39M | $ 1.49M | $ 585.00K | $ 788.00K | $ 0.00 |
| Net Debt | $ -49.70M | $ -21.30M | $ -131.74M | $ -14.58M | $ -131.65M |
| Total Liabilities | $ 37.52M | $ 21.53M | $ 10.54M | $ 9.45M | $ 17.26M |
| Stockholders' Equity | $ 493.40M | $ 352.48M | $ 168.87M | $ 73.66M | $ 172.67M |
| Cash Flow | |||||
| Free Cash Flow | $ -129.27M | $ -78.28M | $ -36.97M | $ -29.21M | $ -60.80M |
| Operating Cash Flow | $ -129.06M | $ -78.18M | $ -36.86M | $ -29.07M | $ -59.53M |
| Investing Cash Flow | $ -122.83M | $ -286.81M | $ 20.25M | $ -59.82M | $ 43.43M |
| Financing Cash Flow | $ 280.13M | $ 255.62M | $ 133.57M | $ 96.68M | $ 89.60M |
Currency in USD
